Wedbush Lifts Earnings Estimates for Travere Therapeutics
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Wedbush upped their FY2024 EPS estimates for...
Your Source for Insightful Trends and Discussions.
Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Wedbush upped their FY2024 EPS estimates for...
Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) insider Peter Heerma sold 1,584 shares of...
Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) fell 4.2% during mid-day trading...